GLI1 (glioma-associated transcription factor 1), a target of SHH signaling first identified in human glioma [151], is a modulator of the expression of stemness genes and self-renewal of CD133+ GSCs, and plays a key role in tumorigenesis [152]. The gene discussed is SHH; the disease is central nervous system cancer.